Dr. Natalie R. Dickson, MD

Dr. Dickson practices at Tennessee Oncology in Franklin, Tennessee.

Dr. Dickson's NPI, 1700839263, was assigned on May 18, 2006. Dr. Dickson holds Tennessee license 30403.

Dr. Dickson's primary practice is Tennessee Oncology, at 4488 Carothers Pkwy, Franklin, TN 37067 in Williamson County. The practice phone is (615) 329-0570.

Dr. Dickson's primary practice is Tennessee Oncology in Franklin, Tennessee. Dr. Dickson is also affiliated with Ascension Saint Thomas Hospital West. The medical group on file is Tennessee Oncology. Dmand AI also links Dr. Dickson to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dickson practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dickson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dickson is licensed in Tennessee.

CMS data shows 5,118 Medicare services from Dr. Dickson across 22 procedure codes in 2024, for 324 Medicare patients. Medicare paid $118,623 for them. Every service was in an office.

CMS counts 324 Medicare patients who saw Dr. Dickson in 2024. The largest group is 65 to 74, with 152 patients. 74% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dickson's median patient age at 70, with 87% women.

In 2024, Dr. Dickson wrote 432 Medicare Part D claims for 114 patients. 66% of them were for generic drugs. CMS names the drug for 342 of them, across 9 drugs with 11 or more claims each, at $1,188,726 in total drug cost. In 2023, CMS named 439 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Dickson for performance year 2024, reported as part of a group. Dr. Dickson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dickson as offering telehealth.

Dmand AI links 18 papers to Dr. Dickson, published from 2016 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Medical Oncology, Lung Neoplasms and Antineoplastic Agents. Dr. Dickson has published most often in JCO Oncol Pract. Dr. Dickson's most frequent co-authors are Blase N. Polite, Stephen Matthew Schleicher, MD and Kerin Bess Adelson, MD.

CMS Open Payments shows 372 general payments to Dr. Dickson from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. Celgene Corporation paid the most, $2,669.